Despite this competitive landscape, there is an opportunity to develop a comprehensive and articulate G7 response on global health including pandemic preparedness and response. While some note the multiple asks circulating from ACT-A, the Global Fund, WHO, the new pandemic financial intermediary fun...

Monkeypox has been around for decades, but it has been low priority for global and public health, despite a notable reemergence of the disease in West and Central Africa in 2017. Now, as the virus reaches 35 countries outside the West and Central African regions, the disease’s current dynamics are s...

In June 2021, Dr. Tedros Ghebreyesus, offered a challenge to the world: “To truly end the pandemic, our goal must be to vaccinate at least 70 percent of the world’s population by the time you meet again in Germany next year.” However, as we approach this year’s G7 summit, the 70 percent target has b...

At a time when governments seem able to agree on very little, the consensus around the Bank’s need to scale up its engagement on climate and other global public goods is striking. But “scaling up ambition” is vague, and there remains a great deal of work to do to pin down what it means in practice f...

In May, the World Bank issued a white paper on a new financial intermediary fund (FIF) for pandemic prevention, preparedness, and response. This document will be the basis for subsequent discussion and approval by the World Bank’s Board, composed of 25 constituencies representing 189 country governm...

COVID-19 has laid bare that the existing global health architecture is not equipped to adequately finance pandemic prevention, preparedness, and response (PPR). Now is the time to act.

In a new paper, we reflect on the current landscape of MCM manufacturing, share lessons learned amid COVID-19, and offer recommendations to the global community to fund MCM purchases on day-zero of the next pandemic.